Position in ACRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,174,044
+$5,290,457 QoQ
Shares Held
1,356,152
+170.0% QoQ
Ownership
0.921%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 149 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. ACRS ranks #20 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in ACRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,174,044 | 1,356,152 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,883,587 | 502,290 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $205,251 | 68,190 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $86,611 | 45,585 | Shares | Sole | 2025-11-13 | |
| 2021-06-30 | $13,152 | 749 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $19,504 | 774 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,007 | 774 | Shares | Sole | 2021-02-10 | |
| 2020-03-31 | $59,441 | 57,155 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||